Abstract
A short-treatment with nondepleting antibodies, such as those targeting CD4 or CD154 (CD40 ligand), allows long-term graft survival without the need for continuous immunosuppression. This state of immune tolerance is maintained by regulatory CD4+ T cells present within both the lymphoid tissue and the tolerated graft. The nature of such regulatory T cells, their relationship to CD4+CD25+ T cells, and their mode of action have all been the subjects of much attention recently. Here, we review recent progress on understanding the nature, specificity, and mechanisms of action of T cells mediating dominant tolerance brought about by antibody therapy.
Similar content being viewed by others
References
Benjamin RJ, Waldmann H: Induction of tolerance by monoclonal antibody therapy. Nature 1986;320: 449–451.
Gutstein NL, Seaman WE, Scott JH, Wofsy D: Induction of immune tolerance by administration of monoclonal antibody to L3T4. J Immunol 1986;137: 1127–1132.
Waldmann H: Reprogramming the immune system. Immunol Rev 2002;185:227–235.
Waldmann H, Cobbold S: Regulating the immune response to transplants a role for CD4+regulatory cells? Immunity 2001;14:399–406.
Li XC, Strom TB, Turka LA, Wells AD: T cell death and transplantation tolerance. Immunity 2001;14:407–416.
Lechler RI, Garden OA, Turka LA: The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003;3:147–158.
Benjamin RJ, Qin SX, Wise MP, Cobbold SP, Waldmann H: Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination. Eur J Immunol 1988;18:1079–1088.
Carteron NL, Wofsy D, Seaman WE: Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+cells. J Immunol 1988;140:713–716.
Carteron NL, Schimenti CL, Wofsy D: Treatment of murine lupus with F(ab') 2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion. J Immunol 1989;142:1470–1475.
Qin SX, Wise M, Cobbold SP, Leong L, Kong YC, Parnes JR, et al.: Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990;20: 2737–2745.
Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H: CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987;17: 1159–1165.
Marshall SE, Cobbold SP, Davies JD, Martin GM, Phillips JM, Waldmann H: Tolerance and suppression in a primed immune system. Transplantation 1996;62:1614–1621.
Chen Z, Cobbold S, Metcalfe S, Waldmann H: Tolerance in the mouse to major histocompatibility complexmismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992;22:805–810.
Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW: Induction of infectious tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996;157:1944–1950.
Isobe M, Yagita H, Okumura K, Ihara A: Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992;255:1125–1127.
Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS: Combinedanti-CD2 andanti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model. J Immunol 1993;151:7249–7259.
Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, et al.: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 1992;257:789–792.
Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, et al.: Survival of mouse pancreatic islet allo grafts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995;92:9560–9564.
Honey K, Cobbold SP, Waldmann H: CD40 ligand blockade induces CD4+T cell tolerance and linked suppression. J Immunol 1999;163: 4805–4810.
Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al.: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434–438.
Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Beming JD, Buchanan K, et al.: Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5:686–693.
Kenyon NS, Chatzipetrou M, Masetti M, Ranuncoli A, Oliveira M, Wagner JL, et al.: Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999;96:8132–8137.
Scully R, Qin S, Cobbold S, Waldmanns H: Mechanisms in CD4 antibody-mediated transplantations tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994;24:2383–2392.
Graca L, Honey K, Adams E, Cobbold SP, Waldmann H: Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol 2000;165:4783–4786.
Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, et al.: Infectious transplantation tolerance. Science 1993;259:974–977.
Chen ZK, Cobbold SP, Waldmann H, Metcalfe S: Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996;62:1200–1206.
Powrie F, Masson D: OX-22 high CD4+T cells induce wasting disease with multiple organ pathology: prevention by the OX-22 low subset. J Exp Med 1990;172:1701–1708.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151–1164.
Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455–458.
Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, et al.: Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190–200.
Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389–400.
Graca L, Thompson S, Lin C-Y, Adams E, Cobbold SP, Waldmann H: Both CD4+CD25+ and CD4+CD25-regulatory cells mediate dominant transplantation tolerance. J Immunol 2002;168:5558–5567.
Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL: CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host diesease. J Exp Med 2002;196:401–406.
Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S: Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002;196:389–399.
Taylor PA, Lees CJ, Blazar BR: The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99:3493–3499.
Kingsley CI, Karim M, Bushell AR, Wood KJ: CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002;168:1080–1086.
van Maurik A, Herber M, Wood KJ, Jones ND: Cutting edge: CD4(+)CD25(+) alloantigen-specific immunoregulatory cells that can prevent CD8(+) T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002;169:5401–5404.
van Maurik A, Wood KJ, Jones ND: Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway. Transplantation 2002;74:740–743.
Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H: T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996;156:3602–3607.
Wong W, Morris PJ, Wood KJ: Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac all ografts: evidence for linked epitope suppression. Transplantation 1997;63:1490–1494.
Graca L, Cobbold SP, Waldmann H: Identification of regulatory T cells in tolerated allografts. J Exp Med 2002;195:1641–1646.
Stockinger B, Barthlott T, Kassiotis G T cell regulation: a special job or everyone's responsibility? Nat Immunol 2001;2:757–758.
Groux H, Bigler M, de Vries JE, Roncarolo MG: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996;184: 19–29.
Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237–1240.
Zelenika D, Adams E, Mellor A, Simpson E, Chandler P, Stockinger B, et al.: Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol 1998;161:1868–1874.
Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, et al.: Regulatory T cells over-express a subset of Th2 gene transcripts. J Immunol 2002;168:1069–1079.
Ciubotariu R, Colovai AI, Pennesi G, Liu Z, Smith D, Berlocco P, et al.: Specific suppressions of human CD4+ Thcell responses to pig MHC antigens by CD8+CD28-regulatory T cells. J Immunol 1998;161:5193–5202.
Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L: Identification of a previously unknown antigen-specific regulatory T cell and its mechanisms of suppression. Nat Med 2000;6:782–789.
Gilliet M, Liu YJ: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002;195:695–704.
Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, et al.: Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999;5:1303–1307.
Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999;5:1298–1302.
Sawitzki B, Lehmann M, Vogt K, Risch K, Brock J, Kupiec-Weglinski JW, et al.: Bag- 1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. Eur J Immunol 2002;32:800–809.
Seddon B, Mason D: The third function of the thymus. Immunol Today 2000;21:95–99.
Hori S, Nomura T, Sakaguchi S: Control of Regulatory T Cell Development by the Transcripton Factor FOXP3. Science 2003;299:1057–1061.
Zelenika D, Adams E, Humm S, Lin C-Y, Waldmann H, Cobbold SP: The role of CD4+T cell subsets in determining transplantation rejection and tolerance. Immunol Rev 2001;182:164–179.
Lin CY, Graca L, Cobbold SP, Waldmann H: Dominant transplantation tolerance impairs CD8(+) T cell function but not expansion. Nat Immunol 2002;3:1208–1213.
Donckier V, Wissing M, Bruyns C, Abramowicz D, Lybin M, Vanderhaeghen ML, et al.: Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995;59:1571–1576.
Davies JD, Martin G, Phillips J, Marshall SE, Cobbold SP, Waldmann H: T cell regulation in adult transplantation tolerance. J Immunol 1996;157:529–533.
Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, et al.: Type 2 helper T cell-type cytokines and the development of “infectious” tolerance in rat cardiac allograft recipients. J Immunol 1997;158:1572–1581.
Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, et al.: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789–3796.
Hall BM, Fava L, Chen J, Plain KM, Boyd RA, Spicer ST, et al.: Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+suppressor T cells that are not dependent upon IL-4. J Immunol 1998;161:5147–5156.
Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL: A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB (low) CD4+T cells. J Exp Med 1996;183:2669–2674.
Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192: 295–302.
Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, et al.: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor betal production and responsiveness. J Exp Med 2002;196:237–246.
Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al.: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303–310.
Sanchez-Fueyo A, Weber M, Domenig C, Strom TB, Zheng XX: Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002;168: 2274–2281.
Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S: Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;22:22.
McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, et al.: CD4(+)CD25(+) Immunoregulatory T Cells. Gene Expression Analysis Reveals a Functional Role for the Glucocorticoid-Induced TNF Receptor. Immunity 2002;16:311–323.
Soares MP, Brouard S, Smith RN, Bach FH: Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 2001;184: 275–285.
Coito AJ, Kupiec-Weglinski JW: Extracellular matrix proteins in organ transplantation. Transplantation 2000;69:2465–2473.
Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F: CD4+CD25+T (R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111–119.
Fairchild PJ, Waldmann H: Dendritic cells and prospects for transplantation tolerance. Curr Opin Immunol 2000;12:528–535.
Jonuleit H, Schmitt E, Steinbrink K, Enk AH: Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001;22:394–400.
Fairchild PJ, Brook FA, Gardner RL, Graca L, Strong V, Tone Y, et al.: Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr Biol 2000;10:1515–1518.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Graca, L., Le Moine, A., Cobbold, S.P. et al. Antibody-induced transplantation tolerance. Immunol Res 28, 181–191 (2003). https://doi.org/10.1385/IR:28:3:181
Issue Date:
DOI: https://doi.org/10.1385/IR:28:3:181